[The clinical use of bis-(hydroxy-ethyl-thio)-1,10-decane in the treatment of hyperlipemic and dyslipemic conditions].
作者信息
Vailati G, Montini M, Simonutti M, Nosari I, Pagani G
出版信息
Clin Ter. 1978 May 31;85(4):361-73.
PMID:668273
Abstract
摘要
相似文献
1
2
[Indications and limitations of tiadenol therapy of dyslipidemia in the elderly].[替亚地诺治疗老年人血脂异常的适应证与局限性]
G Clin Med. 1979 Jan;60(1):49-64.
3
[Clinical trials with Fonlipol. Apropos of 50 cases].[使用福脂醇的临床试验。关于50例病例]
Lille Med. 1974 Apr;19(4 Suppl 11):528-31.
4
[Bis-(hydroxy-2-ethylthyo)-1,10-decano in hyperlipaemic therapy (author's transl)].双（2-羟乙基硫代）-1,10-癸二醇在高脂血症治疗中的应用（作者译）
G Ital Cardiol. 1977;7(3):248-64.
5
6
The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):78-9. doi: 10.1177/00359157760690S219.
7
A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.吉非贝齐治疗高脂血症的长期试验。
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):49-52. doi: 10.1177/00359157760690S213.
8
[Tiadenol in the treatment of primary hyperlipidemias].替亚德诺治疗原发性高脂血症
G Clin Med. 1981 Jan;62(1):51-64.
9
[Clinical study of thiadenol in diabetic hyperdyslipemia as compared with clofibrate].[噻地诺与氯贝丁酯治疗糖尿病性高脂血症的临床研究]
Clin Ter. 1979 Aug 15;90(3):241-50.
10
Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
Int Z Klin Pharmakol Ther Toxikol. 1969 Oct;2(4):348-53.
Zotero 插件